Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 4 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 208 Neoplasms 130 Polycystic Ovary Syndrome 107 Carcinoma, Hepatocellular 82 Colorectal Neoplasms 77 Prostatic Neoplasms 70 Stomach Neoplasms 55 Lung Neoplasms 51 Precursor Cell Lymphoblastic Leukemia-Lymphoma 49 Carcinoma, Non-Small-Cell Lung 43 Pain, Postoperative 42 Pancreatic Neoplasms 41 Head and Neck Neoplasms 38 Pain 37 Liver Neoplasms 36 Leukemia, Myeloid, Acute 32 Leiomyoma 32 Keratosis, Actinic 31 Colonic Neoplasms 31 Recurrence 30 Neoplasm Metastasis 29 Multiple Myeloma 28 Infertility 28 Brain Neoplasms 28 Uterine Cervical Neoplasms 26 Urinary Bladder Neoplasms 24 Ovarian Neoplasms 24 Lymphoma 24 Esophageal Neoplasms 23 Obesity 22

Interventions

Morphine 1 Gastrostomy 1 Fentanyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × OTHER × Breakthrough Pain × Clear all

NCT02869321 2019-05-13

ANTALGIP

Central Hospital, Nancy, France

Phase 4 Completed

Head and Neck Neoplasms, Breakthrough Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡